HB308

Kentucky HB308 mandates medroxyprogesterone acetate treatment for sex offenders with victims under 12.

Kentucky HB308 introduces a new section in KRS Chapter 532 requiring individuals convicted of sex crimes with victims under 12 to undergo medroxyprogesterone acetate treatment. This treatment must begin one month before release from custody and continue until the end of probation, parole, or postincarceration supervision. The treatment is administered by the Department of Corrections or a contracted entity. The offender must pay for the treatment unless deemed needy or indigent, in which case the Commonwealth covers the costs.